EcoDrugPlus

Nuclear Receptor Subfamily 1, Group H, Member 4

Ensembl ID : ENSMSIG00000017294
Gene Symbol: NR1H4
1 Cross references
402 Possible Orthologues:

Nuclear Receptor Subfamily 3, Group C, Member 1

Ensembl ID : ENSMSIG00000012342
Gene Symbol: NR3C1
1 Cross references
293 Possible Orthologues:

Nuclear Receptor Subfamily 3, Group C, Member 2

Ensembl ID : ENSMSIG00000009936
Gene Symbol: NR3C2
1 Cross references
227 Possible Orthologues:

Nucleophosmin 1

Ensembl ID : ENSMSIG00000023445
Gene Symbol: NPM1
1 Cross references
302 Possible Orthologues:

Nucleotide-Binding Oligomerization Domain Containing 2

Ensembl ID : ENSMSIG00000023038
Gene Symbol: NOD2
1 Cross references
181 Possible Orthologues:

Opioid Receptor, Delta 1

Ensembl ID : ENSMSIG00000009620
Gene Symbol: OPRD1
1 Cross references
267 Possible Orthologues:

Opioid Receptor, Kappa 1

Ensembl ID : ENSMSIG00000018025
Gene Symbol: OPRK1
1 Cross references
277 Possible Orthologues:

Opioid Receptor, Mu 1

Ensembl ID : ENSMSIG00000025261
Gene Symbol: OPRM1
1 Cross references
229 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSMSIG00000027756
Gene Symbol: OXTR
1 Cross references
277 Possible Orthologues:

P21 (Rac1) Activated Kinase 4

Ensembl ID : ENSMSIG00000000463
Gene Symbol: PAK4
1 Cross references
163 Possible Orthologues:

Pancreatic Lipase

Ensembl ID : ENSMSIG00000028475
Gene Symbol: PNLIP
1 Cross references
306 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSMSIG00000025217
Gene Symbol: PTH1R
1 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).